Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1630-2020Class II

natus newborn care Olympic Brainz Monitor, REF OBM00002. electroencephalograph

Natus Medical Incorporated / initiated 2020-03-05 / Terminated / root cause: manufacturing process

Natus Neurology DBA Excel Tech., Ltd. (XLTEK) began a recall of natus newborn care Olympic Brainz Monitor, REF OBM00002. electroencephalograph on . FDA classified it as Class II and gives the reason as "The OBM system functional test (impedance and noise) was not carried out on the affected items prior to release to the customer. The manufacturer cannot attest to the system functionality of the affected items". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1630-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Natus Medical Incorporated
Product
natus newborn care Olympic Brainz Monitor, REF OBM00002. electroencephalograph
Product code
OMA Amplitude-Integrated Electroencephalograph
Reason for recall
The OBM system functional test (impedance and noise) was not carried out on the affected items prior to release to the customer. The manufacturer cannot attest to the system functionality of the affected items.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Natus initiated the recall by letter on 03/05/2020. the firm asked customers to return the affected units to Natus Medical Incorporated, 5900 First Avenue, Seattle, WA 98108, USA. Testing will be performed by Natus on the returned unit and will be returned to the consignee following completion of testing. Natus will provide a temporary replacement unit during this time.
Quantity in commerce
40 units
Distribution
Worldwide distribution. US nationwide, Australia, Dominican Republic, United Arab Emirates, Israel, Italy, Hong Kong, Korea, Hungary, Switzerland, Colombia, and United Kingdom
Product codes and lots
Serial Numbers: OBM00002G2119, OBM00002G2130, OBM00002G2131, OBM00002G2132, OBM00002G2133, OBM00002G2134, OBM00002G2135, OBM00002G2136, OBM00002G2137, OBM00002G2138, OBM00002G2139, OBM00002G2140, OBM00002G2141, OBM00002G2142, OBM00002G2143, OBM00002G2144, OBM00002G2145, OBM00002G2146, OBM00002G2147, OBM00002G2148, OBM00002G2149, OBM00002G2150, OBM00002G2151, OBM00002G2152, OBM00002G2153, OBM00002G2154, OBM00002G2155, OBM00002G2156, OBM00002G2157, OBM00002G2158, OBM00002G2159, OBM00002G2160, OBM00002G2161, OBM00002G2162, OBM00002G2163, OBM00002G2164, OBM00002G2165, OBM00002G2166, OBM00002G2167, OBM00002G2168

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1630-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1630-2020Class IITerminatedVoluntary: Firm initiated